The Latest Cardiac and Vascular News
DANVERS, Mass.–(BUSINESS WIRE)–The highest court in Germany, the Federal Court of Justice, recently ruled in favor of Abiomed (NASDAQ: ABMD) in a patent challenge filed by Thoratec in 2015 and validated the strengths of Abiomed’s Impella-related patents. These patents are also the subject of a separate patent infringement action Abiomed […]
Improved Functionality Across Four Valve Sizes and Lowest Delivery Profile on the Market, the Evolut PRO+ TAVR System Launches in U.S. as TAVR Patient Population Grows DUBLIN, Sept. 23, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, today announced U.S. Food and Drug Administration […]
Pre-Specified Interim Review Demonstrated Beneficial Changes in Markers of Cardiovascular Health – CRP, LDL, total cholesterol, triglycerides, oxidized LDL, and blood pressure reduced – Interim results support excellent safety profile – Enrollment continues HONOLULU, Sept. 23, 2019 /PRNewswire/ — Cardax, Inc. (OTCQB: CDXI) today announced results from the pre-specified interim review of its […]
TORONTO, Sept. 23, 2019 /PRNewswire/ – Baylis Medical announced today the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped pigtail wire. The device is designed to achieve left-heart access with controlled precision, while reducing the […]
To demonstrate that treatment with the Revivent TC™ System is more effective than Guideline Directed Medical Therapy (GDMT) for the treatment of ischemic heart failure SAN RAMON, Calif., Sept. 23, 2019 /PRNewswire/ — The Revivent TC™ System has continued to deliver impressive results when evaluating post-market data in Europe. The last 35 consecutive cases […]
CALGARY, Alberta, Sept. 23, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today the Late Breaking Science submission, regarding the primary results of the BETonMACE trial, has been accepted by the American Heart Association (“AHA”) for presentation during Scientific Sessions 2019 held in Philadelphia, Pennsylvania. The trial results […]
Post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin based on the number of cardiovascular risk factor goals achieved.1 Findings from the post-hoc analysis were presented at the 55th Annual Meeting of the European Association for the Study […]
Initial program aims to reduce congestive heart failure readmissions with potential savings of about $1M ATLANTA, Sept. 18, 2019 (GLOBE NEWSWIRE) — Jvion, a leader in AI-enabled prescriptive analytics for preventable harm, today announced a partnership with Novant Health as part of the newly launched Novant Health Institute of Innovation & Artificial Intelligence. Working […]
SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — Abcentra, a clinical-stage bio-pharmaceutical company that addresses unmet needs in inflammation, today announced its contribution to a 2019 study published in the American Heart Association Journals. The study found that, in those with high-cholesterol and major histocompatibility complex class II (MHCII) cells, treating atherosclerosis with immunotherapy […]
– World’s smallest pediatric treatments pioneered by Abbott address critical needs for the most vulnerable patients: babies and children born with common congenital heart defects – Includes pediatric mechanical heart valve and first minimally invasive device to treat premature babies and newborns born with an opening in their heart […]
